In this study, we found that five of six canonical Wnt ligands (Wnt1, 3, 3a, 8b and 10b) in bone sarcoma cells were prominently increased, while Wnt2 expression was remarkably decreased. This evidence concerns the gene WNT1 and bone sarcoma.